Cargando…

环状RNA在肺癌中的研究进展

Lung cancer is the most common malignant tumor with the highest morbidity and mortality worldwide, and its imposes an insupportable burden on patients due to its poor prognosis. The diagnosis and treatment of lung cancer is under great pressure. Therefore, it is urgent to explore effective therapeut...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786223/
https://www.ncbi.nlm.nih.gov/pubmed/33357317
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.38
_version_ 1783632581190746112
collection PubMed
description Lung cancer is the most common malignant tumor with the highest morbidity and mortality worldwide, and its imposes an insupportable burden on patients due to its poor prognosis. The diagnosis and treatment of lung cancer is under great pressure. Therefore, it is urgent to explore effective therapeutic targets and molecular markers. Circular RNA (circRNA) is a kind of covalently closed non-coding RNAs, which has attracted much attention due to its conservation, stability and tissue specificity. Many studies have found that circRNA participates in the regulation of lung cancer through various mechanisms such as sponging miRNA and plays a part vital role in the early diagnosis, treatment and prognosis evaluation. In recent years, there have been numerous studies on circRNA in lung cancer. This paper summarizes the current progress of circRNA in the diagnosis, treatment and prognosis of lung cancer.
format Online
Article
Text
id pubmed-7786223
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-77862232021-01-14 环状RNA在肺癌中的研究进展 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is the most common malignant tumor with the highest morbidity and mortality worldwide, and its imposes an insupportable burden on patients due to its poor prognosis. The diagnosis and treatment of lung cancer is under great pressure. Therefore, it is urgent to explore effective therapeutic targets and molecular markers. Circular RNA (circRNA) is a kind of covalently closed non-coding RNAs, which has attracted much attention due to its conservation, stability and tissue specificity. Many studies have found that circRNA participates in the regulation of lung cancer through various mechanisms such as sponging miRNA and plays a part vital role in the early diagnosis, treatment and prognosis evaluation. In recent years, there have been numerous studies on circRNA in lung cancer. This paper summarizes the current progress of circRNA in the diagnosis, treatment and prognosis of lung cancer. 中国肺癌杂志编辑部 2020-12-20 /pmc/articles/PMC7786223/ /pubmed/33357317 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.38 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 综述
环状RNA在肺癌中的研究进展
title 环状RNA在肺癌中的研究进展
title_full 环状RNA在肺癌中的研究进展
title_fullStr 环状RNA在肺癌中的研究进展
title_full_unstemmed 环状RNA在肺癌中的研究进展
title_short 环状RNA在肺癌中的研究进展
title_sort 环状rna在肺癌中的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786223/
https://www.ncbi.nlm.nih.gov/pubmed/33357317
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.38
work_keys_str_mv AT huánzhuàngrnazàifèiáizhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàifèiáizhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàifèiáizhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàifèiáizhōngdeyánjiūjìnzhǎn